SEARCH RESULTS
 
Showing 1-5 of 5 records
1
 
Expand article

FDA Approves Abbott's Everolimus Eluting Stent

The Article has images
2008-07-07 13:20:44 by Michael in Medgadget
...TAXUS. The FDA approved XIENCE V based, in large part, on superior results from the 1,002 patient SPIRIT III U.S. pivotal clinical trial, in which XIENCE V demonstrated statistical superiority to TAXUS on the study's primary endpoint of in-segment late loss (vessel renarrowing) at eight months, with a statistically significant 50 percent...
 
Tags: stent, percent, percent reduction, abbott, fda approves abbott, xience, stent market, vessel, target vessel failure
 
 
 
 
Expand article

WSJ: Boston Scientific Stent Study Flawed

The Article has images
2008-08-14 21:21:56 by Michael in Medgadget
...Taxus Liberté coronary stent. The study, published in the Journal of the American College of Cardiology in 2007, found that Taxus Liberté stent wasn't inferior to the Taxus Express stent, an already approved device from the company From the article: Boston Scientific, of Natick, Mass., has roughly 40% of the $5 billion a year world-wide...
 
Tags: study, express, taxus express stent, boston scientific, liberte stent, liberte, study abstract, taxus express, liberte study
 
 
 
 
Expand article

Medtronic's Endeavor Drug-Eluting Stent Approved by FDA

The Article has images
2008-02-01 18:25:31 by Michael in Medgadget
...Taxus stent, met its primary endpoint, with a target vessel failure (TVF) rate in Endeavor patients of 6.6 percent at nine months. The TVF rate for Taxus patients at nine months was 7.2 percent. Importantly, Endeavor had similar efficacy compared to Taxus for all lesion subsets analyzed, and there were no statistically significant differences...
 
Tags: endeavor, stent, endeavor stent, taxus, taxus patients, endeavor patients, stent thrombosis, taxus stent, coronary stent system
 
 
 
 
Expand article

Ins and Outs

2007-12-26 16:06:49 by Michael in Medgadget
 
...TAXUS Liberte Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients ... [Boston Scientific Hospitals Look to Nuclear Tool to Fight Cancer ... [NY Times CA state court puts limits on health insurers' policy cancellations ... [SF Chronicle Medtronic Resolves Marquis Defibrillator Lawsuits ... [Medtronic FDA Warns...
 
Tags: fda, fda approves kuvan, fda issues, fda warns, stem cell line, fresh skin cells, fentanyl skin patch, taxus liberte, policy cancellations
 
 
 
 
Expand article

Ins and Outs

The Article has images
2008-03-31 22:16:13 by Michael in Medgadget
...TAXUS Express Stent... [Boston Scientific Allergan and J&J Pump Up Weight-Loss Surgery ... [WSJ Riding the Hospitalist Boom to an IPO ... [WSJ Big Insurers Pay for Online Doctor Visits ... [WSJ Nanomedicine System Engineered To Enhance Therapeutic Effects of Injectable Drugs... [NCI Alliance for Nanotechnology in Cancer Astrotechnology...
 
Tags: stent, taxus express stent, stent platforms, boston scientific, multi-center study suggests, multi-center study, nci alliance, coronary stent system, johns hopkins
 
 
 
 
 
Showing 1-5 of 5 records
1
 


SPONSORED LINKS